References
-
1) Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance.
Product: CALR Antibody (#DF3139)Year: 2024Journal: ACS NanoImpactFactor: 15.8DOI: 10.1021/acsnano.3c10117PMID: 38227812 -
2) Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy.
Product: CALR Antibody (#DF3139)Year: 2024Journal: Acta Pharm Sin BImpactFactor: 14.7DOI: 10.1016/j.apsb.2024.05.028PMID: 39309498 -
3) Multifunctional 3D-printed scaffolds eradiate orthotopic osteosarcoma and promote osteogenesis via microwave thermo-chemotherapy combined with immunotherapy.
Product: CALR Antibody (#DF3139)Year: 2023Journal: BiomaterialsImpactFactor: 12.8DOI: 10.1016/j.biomaterials.2023.122236PMID: 37506512 -
4) In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti-Tumor Immune Responses.
Product: CALR Antibody (#DF3139)Year: 2022Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202102781PMID: 35285581 -
5) Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer.
Product: CALR Antibody (#DF3139)Year: 2022Journal: Acta Pharm Sin BImpactFactor: 14.7DOI: 10.1016/j.apsb.2022.02.021PMID: 36176911 -
6) HMGB2 promotes chondrocyte proliferation under negative pressure through the phosphorylation of AKT.
Product: HMGB2 Antibody (#DF3133)Year: 2021Journal: BBA-MOL CELL RESImpactFactor: 4.6DOI: 10.1016/j.bbamcr.2021.119115PMID: 34333060 -
7) HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Product: hnRNP A2/B1 Antibody (#DF3122)Year: 2022Journal: J TRANSL MEDImpactFactor: 7.4DOI: 10.1186/s12967-022-03750-8PMID: 36401285 -
8) Mailuo Shutong pills inhibit neuroinflammation by regulating glucose metabolism disorders to protect mice from cerebral ischemia-reperfusion injury.
Product: Hexokinase 1 Antibody (#DF3112)Year: 2024Journal: J EthnopharmacolImpactFactor: 4.8DOI: 10.1016/j.jep.2024.118621PMID: 39053718 -
9) A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development.
Product: ATF3 Antibody (#DF3110)Year: 2023Journal: LeukemiaImpactFactor: 12.8DOI: 10.1038/s41375-023-01923-yPMID: 37157016 -
10) NOX4 stimulates ANF secretion via activation of the Sirt1/Nrf2/ATF3/4 axis in hypoxic beating rat atria.
Product: ATF3 Antibody (#DF3110)Year: 2022Journal: MOL MED REPImpactFactor: 3.4DOI: 10.3892/mmr.2022.12600PMID: 35029280 -
11) Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease.
Product: ATF3 Antibody (#DF3110)Year: 2021Journal: LIFE SCIImpactFactor: 5.2DOI: 10.1016/j.lfs.2020.118986PMID: 33385408 -
12) Src-IL-18 signaling regulates the secretion of atrial natriuretic factor in hypoxic beating rat atria.
Product: ATF3 Antibody (#DF3110)Year: 2021Journal: KARDIOL POLImpactFactor: 3.7DOI: 10.33963/KP.a2021.0051PMID: 34176112 -
13) Norepinephrine protects against cochlear outer hair cell damage and noise-induced hearing loss via α2A-adrenergic receptor.
-
14) N-Acetylcysteine assists muscle development in offspring of mice subjected to maternal heat stress during pregnancy.
Product: MYF5 Antibody (#DF3089)Year: 2024Journal: J Sci Food AgricImpactFactor: 3.3DOI: 10.1002/jsfa.13620PMID: 38828636 -
15) SOX4 facilitates brown fat development and maintenance through EBF2-mediated thermogenic gene program in mice.
Product: MYF5 Ab (#DF3089)Year: 2024Journal: CELL DEATH DIFFERImpactFactor: 13.7DOI: 10.1038/s41418-024-01397-0